CoChat

Glucagon Control on Food Intake and Energy Balance

Open access
Al-Massadi, Omar, Fernø, Johan, Diéguez, Carlos, Nogueiras, Ruben, Quiñones, Mar · 2019 · International Journal of Molecular Sciences
Cited by 88

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Glucagon exerts pleiotropic actions on energy balance and has emerged as an attractive target for the treatment of diabetes and obesity in the last few years. Glucagon reduces body weight and adiposity by suppression of appetite and by modulation of lipid metabolism. Moreover, this hormone promotes weight loss by activation of energy expenditure and thermogenesis. In this review, we cover these metabolic actions elicited by glucagon beyond its canonical regulation of glucose metabolism. In addition, we discuss recent developments of therapeutic approaches in the treatment of obesity and diabetes by dual- and tri-agonist molecules based on combinations of glucagon with other peptides. New strategies using these unimolecular polyagonists targeting the glucagon receptor (GCGR), have become successful approaches to evaluate the multifaceted nature of glucagon signaling in energy balance and metabolic syndrome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms20163905

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Research works printed but not linked: 63

  1. 1923, Aqueous extracts of pancreas. III. Some precipitaton reactions to insulin, J. Biol. Chem., 58, 337
  2. Quesada, 2008, Physiology of the pancreatic alpha-cell and glucagon secretion: Role in glucose homeostasis and diabetes, J. Endocrinol., 199, 5, 10.1677/JOE-08-0290 · DOI · Paper page
  3. Han, 1986, Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain, J. Neurosci. Res., 16, 97, 10.1002/jnr.490160110 · DOI · Paper page
  4. Drucker, 1988, Glucagon gene expression in vertebrate brain, J. Biol. Chem., 263, 13475, 10.1016/S0021-9258(18)68261-4 · DOI · Paper page
  5. Ohneda, 1988, Effect of glicentin-related peptides upon the secretion of insulin and glucagon in the canine pancreas, Tohoku J. Exp. Med., 155, 197, 10.1620/tjem.155.197 · DOI
  6. Whiting, L., Stewart, K.W., Hay, D.L., Harris, P.W., Choong, Y.S., Phillips, A.R., Brimble, M.A., and Cooper, G.J. (2015). Glicentin-related pancreatic polypeptide inhibits glucose-stimulated insulin secretion from the isolated pancreas of adult male rats. Physiol. Rep., 3. · DOI
  7. Shi, 2013, Central GLP-2 enhances hepatic insulin sensitivity via activating PI3K signaling in POMC neurons, Cell Metab., 18, 86, 10.1016/j.cmet.2013.06.014 · DOI · Paper page
  8. Schmidt, 2003, Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety, Regul. Pept., 116, 21, 10.1016/S0167-0115(03)00175-7 · DOI
  9. Schmidt, 1985, Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets, Diabetologia, 28, 704, 10.1007/BF00291980 · DOI · Paper page
  10. Holst, 1994, Proglucagon processing in porcine and human pancreas, J. Biol. Chem., 269, 18827, 10.1016/S0021-9258(17)32241-X · DOI · Paper page
  11. Segre, 1993, Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family, Trends Endocrinol. Metab., 4, 309, 10.1016/1043-2760(93)90071-L · DOI · Paper page
  12. Svoboda, 1994, Relative quantitative analysis of glucagon receptor mRNA in rat tissues, Mol. Cell. Endocrinol., 105, 131, 10.1016/0303-7207(94)90162-7 · DOI
  13. Kieffer, 1996, Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets, Endocrinology, 137, 5119, 10.1210/endo.137.11.8895386 · doi:10.1210/endo.137.11.8895386 · Paper page
  14. Schulman, 1957, Effect of glucagon on food intake and body weight in man, J. Appl. Physiol., 11, 419, 10.1152/jappl.1957.11.3.419 · DOI · Paper page
  15. Penick, 1961, Depression of food intake induced in healthy subjects by glucagon, N. Engl. J. Med., 264, 893, 10.1056/NEJM196105042641801 · DOI · Paper page
  16. Geary, 2001, Estradiol increases glucagon’s satiating potency in ovariectomized rats, Am. J. Physiol. Regul. Integr. Comp. Physiol., 281, R1290, 10.1152/ajpregu.2001.281.4.R1290 · DOI · Paper page
  17. Noh, 1991, Hepatic portal infusion of glucagon antibodies increases spontaneous meal size in rats, Am. J. Physiol., 261, R162
  18. Raben, 1994, Evidence for an abnormal postprandial response to a high-fat meal in women predisposed to obesity, Am. J. Physiol., 267, E549
  19. Nilsson, 1977, Effect of teasing and sham feeding on plasma glucagon concentration in dogs, Acta Physiol. Scand., 100, 298, 10.1111/j.1748-1716.1977.tb05953.x · DOI
  20. Weatherford, 1988, Lesion of vagal afferent terminals impairs glucagon-induced suppression of food intake, Physiol. Behav., 43, 645, 10.1016/0031-9384(88)90220-X · DOI
  21. Inokuchi, 1984, Effect of intracerebroventricularly infused glucagon on feeding behavior, Physiol. Behav., 33, 397, 10.1016/0031-9384(84)90160-4 · DOI
  22. Banks, 1985, Peptides and the blood-brain barrier: Lipophilicity as a predictor of permeability, Brain Res. Bull., 15, 287, 10.1016/0361-9230(85)90153-4 · DOI · Paper page
  23. Hoosein, 1984, Identification of glucagon receptors in rat brain, Proc. Natl. Acad. Sci. USA, 81, 4368, 10.1073/pnas.81.14.4368 · DOI · Paper page
  24. Chan, 1984, Suppression of weight gain by glucagon in obese Zucker rats, Exp. Mol. Pathol., 40, 320, 10.1016/0014-4800(84)90049-2 · DOI
  25. Bloom, 1987, Glucagonoma syndrome, Am. J. Med., 82, 25, 10.1016/0002-9343(87)90424-4 · doi:10.1016/0002-9343(87)90424-4
  26. Gelling, 2003, Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice, Proc. Natl. Acad. Sci. USA, 100, 1438, 10.1073/pnas.0237106100 · DOI · Paper page
  27. Bryce, 1977, Insulin and glucagon: Plasma levels and pancreatic release in the genetically obese Zucker rat, Horm. Metab. Res., 9, 366, 10.1055/s-0028-1093529 · doi:10.1055/s-0028-1093529
  28. Kim, 2018, Glucagon Receptor Signaling Regulates Energy Metabolism via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21, Diabetes, 67, 1773, 10.2337/db17-1502 · DOI · Paper page
  29. Doi, 1982, Modified metabolic responsiveness to glucagon in cold-acclimated and heat-acclimated rats, Life Sci., 30, 785, 10.1016/0024-3205(82)90614-2 · DOI
  30. Seitz, 1981, Rapid rise in plasma glucagon induced by acute cold exposure in man and rat, Pflug. Arch. Eur. J. Physiol., 389, 115, 10.1007/BF00582100 · DOI
  31. Kinoshita, 2014, Glucagon is essential for adaptive thermogenesis in brown adipose tissue, Endocrinology, 155, 3484, 10.1210/en.2014-1175 · DOI · Paper page
  32. Beaudry, 2019, The brown adipose tissue glucagon receptor is functional but not essential for control of energy homeostasis in mice, Mol. Metab., 22, 37, 10.1016/j.molmet.2019.01.011 · DOI · Paper page
  33. Atrens, 1993, Glucagon and the paraventricular hypothalamus: Modulation of energy balance, Brain Res., 630, 245, 10.1016/0006-8993(93)90663-8 · DOI
  34. Billington, 1987, Glucagon stimulation of brown adipose tissue growth and thermogenesis, Am. J. Physiol., 252, R160
  35. Dicker, 1998, Apparent thermogenic effect of injected glucagon is not due to a direct effect on brown fat cells, Am. J. Physiol., 275, R1674
  36. Caren, 1960, Glucagon and cholesterol metabolism, Metab. Clin. Exp., 9, 938
  37. Paloyan, 1961, Glucagon as a regulating factor of plasma lipids, Metab. Clin. Exp., 10, 315
  38. Guettet, 1991, Effect of chronic glucagon administration on the metabolism of triacylglycerol-rich lipoproteins in rats fed a high sucrose diet, J. Nutr., 121, 24, 10.1093/jn/121.1.24 · DOI
  39. Caren, 1970, Transfer of plasma lipid to platelets by action of glucagon, Metab. Clin. Exp., 19, 598, 10.1016/0026-0495(70)90016-8 · DOI
  40. Penhos, 1966, Effect of glucagon on the metabolism of lipids and on urea formation by the perfused rat liver, Diabetes, 15, 740, 10.2337/diab.15.10.740 · DOI · Paper page
  41. Eaton, 1973, Hypolipemic action of glucagon in experimental endogenous lipemia in the rat, J. Lipid Res., 14, 312, 10.1016/S0022-2275(20)36889-9 · DOI · Paper page
  42. Guettet, 1988, Effects of chronic glucagon administration on cholesterol and bile acid metabolism, Biochim. Et Biophys. Acta, 963, 215, 10.1016/0005-2760(88)90283-4 · DOI
  43. Guettet, 1989, Effects of chronic glucagon administration on rat lipoprotein composition, Biochim. Et Biophys. Acta, 1005, 233, 10.1016/0005-2760(89)90042-8 · DOI
  44. Guettet, 1991, Effect of chronic glucagon administration on lipoprotein composition in normally fed, fasted and cholesterol-fed rats, Lipids, 26, 451, 10.1007/BF02536072 · DOI · Paper page
  45. Perea, 1995, Physiological effect of glucagon in human isolated adipocytes, Horm. Metab. Res., 27, 372, 10.1055/s-2007-979981 · DOI · Paper page
  46. Mitchell, 1969, Growth-hormone release by glucagon, Lancet, 1, 289, 10.1016/S0140-6736(69)91041-1 · DOI
  47. Waldhausl, 1976, ACTH and cortisol responses to glucagon stimulation, J. Clin. Endocrinol. Metab., 43, 675, 10.1210/jcem-43-3-675 · DOI
  48. Sarcione, 1963, Elevation of plasma epinephrine levels produced by glucagon in vivo, Endocrinology, 72, 523, 10.1210/endo-72-4-523 · DOI
  49. Pegorier, 1989, Induction of ketogenesis and fatty acid oxidation by glucagon and cyclic AMP in cultured hepatocytes from rabbit fetuses. Evidence for a decreased sensitivity of carnitine palmitoyltransferase I to malonyl-CoA inhibition after glucagon or cyclic AMP treatment, Biochem. J., 264, 93, 10.1042/bj2640093 · DOI · Paper page
  50. Vons, 1991, Regulation of fatty-acid metabolism by pancreatic hormones in cultured human hepatocytes, Hepatology, 13, 1126, 10.1002/hep.1840130620 · DOI · Paper page
  51. Ontko, 1966, Correlation between concentrations of circulating free fatty acids and ketone bodies, Proc. Soc. Exp. Biol. Med., 121, 319, 10.3181/00379727-121-30768 · DOI
  52. Dixon, 1969, Hepatic lipid metabolism in experimental diabetes. V. The effect of concentration of oleate on metabolism of triglycerides and on ketogenesis, J. Biol. Chem., 244, 2278, 10.1016/S0021-9258(19)78223-4 · DOI · Paper page
  53. Gerich, 1975, Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon, N. Engl. J. Med., 292, 985, 10.1056/NEJM197505082921901 · DOI · Paper page
  54. Schade, 1976, Modulation of fatty acid metabolism by glucagon in man. IV. Effects of a physiologic hormone infusion in normal man, Diabetes, 25, 978, 10.2337/diab.25.10.978 · DOI · Paper page
  55. Parrilla, 1974, Effect of glucagon: Insulin ratios on hepatic metabolism, Diabetes, 23, 725, 10.2337/diab.23.9.725 · DOI · Paper page
  56. Genuth, 1973, Constant intravenous insulin infusion in diabetic ketoacidosis, JAMA, 223, 1348, 10.1001/jama.1973.03220120020004 · DOI · Paper page
  57. Wellman, 1999, Synergistic interactions between fenfluramine and phentermine, Int. J. Obes. Relat. Metab. Disord., 23, 723, 10.1038/sj.ijo.0800920 · DOI
  58. Tschop, 2016, Unimolecular Polypharmacy for Treatment of Diabetes and Obesity, Cell Metab., 24, 51, 10.1016/j.cmet.2016.06.021 · DOI · Paper page
  59. Quinones, 2019, Exciting advances in GPCR-based drugs discovery for treating metabolic disease and future perspectives, Expert Opin. Drug Discov., 14, 421, 10.1080/17460441.2019.1583642 · DOI
  60. Clemmensen, 2014, GLP-1/glucagon coagonism restores leptin responsiveness in obese mice chronically maintained on an obesogenic diet, Diabetes, 63, 1422, 10.2337/db13-1609 · DOI · Paper page
  61. Pocai, 2009, Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice, Diabetes, 58, 2258, 10.2337/db09-0278 · DOI · Paper page
  62. Bhat, 2013, A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties, Biochem. Pharmacol., 85, 1655, 10.1016/j.bcp.2013.03.009 · DOI
  63. Bhat, 2013, A DPP-IV-resistant triple-acting agonist of GIP, GLP-1 and glucagon receptors with potent glucose-lowering and insulinotropic actions in high-fat-fed mice, Diabetologia, 56, 1417, 10.1007/s00125-013-2892-2 · DOI

Cited by

Metadata

Authors
Al-Massadi, O., Fernø, J., Diéguez, C., Nogueiras, R., & Quiñones, M.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2019-08-11
Volume
20
Issue
16
Pages
3905
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2967453995
Cited by
88
References
26
FWCI
2.54
Type
journal article
Language
en
Open access
gold
Funders
  • Ministerio de Economia y Competitividad (BFU2015-70664R)
  • Xunta de Galicia (RN: 2015-CP080 and 2016-PG057, MQ: ED481B2018/004)
  • European Community Seventh Framework Programme (RN: ERC-2011-StG-OBESITY53-281408)
  • Centro de Investigación Biomédica en Red (CIBER) de Fisiopatología de la Obesidad y Nutrición (CIBERobn)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.